Insulin Industry, March 2015 Market Reports from Top Publishers

You might be interested in: medical equipment, drug, drug delivery, therapeutics, protein, diabetes therapeutics, biosimilar, human insulin, insulin delivery, medical, syringe, cartridge, growth hormone, human growth hormone, industrial construction.


 
1-10 of 96 reports for Insulin

Incretin-Based Drugs: Markets for Diabetes Therapies and Developing Treatments

Incretin-Based Drugs: Markets for Diabetes Therapies and Developing Treatments

  • $ 6 650
  • Industry report
  • February 2015
  • by BCC Research

REPORT HIGHLIGHTS The global market for incretin-based therapeutics was valued at nearly $11.8 billion in 2013 and $12.7 billion in 2014. This market is expected to reach $22.8 billion by 2019, with a ...

Insuline Medical Ltd

Insuline Medical Ltd

  • $ 55
  • Company report
  • January 2015
  • by Wright Investors' Service

A textual analysis of the financial results for Insuline Medical Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

Insulin Resistance - Pipeline Review, H1 2015

Insulin Resistance - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Insulin Resistance - Pipeline Review, H1 2015 Summary Global Markets Direct's, ‘Insulin Resistance - Pipeline Review, H1 2015', provides an overview of the Insulin Resistance's therapeutic pipeline. ...

Cardiometabolic Drug News JANUARY 2015

Cardiometabolic Drug News JANUARY 2015

  • $ 1 114
  • Industry report
  • January 2015
  • by Espicom Business Intelligence

Industry Brief - X-Chem Licenses Cardiovascular Drug-Discovery Programme To Bayer Industry Brief - La Jolla/GWU Enter Licence Agreement Covering IP Relating To LJPC-501 Industry Brief - Lilly/Adocia To ...

Oral Thin Films Market, 2015 - 2025

Oral Thin Films Market, 2015 - 2025

  • $ 1 899
  • Industry report
  • January 2015
  • by Roots Analysis Private Ltd.

INTRODUCTION Oral drug delivery technologies form an integral part of the pharmaceutical industry. From the conventional tablets / capsules to modern-day fast disintegrating and rapidly acting tablets ...

Global Continuous Glucose Monitoring System (CGM Market, Real Time Monitoring, Integrated Insulin Pumps, Blood Glucose, Manufacturers, Global Health, IPRO Glucose, MARD, SMBG, Growing Diabetic Population, Type 1&2 Diabetes, Nocturnal  Hypoglycemia) - Gluc

Global Continuous Glucose Monitoring System (CGM Market, Real Time Monitoring, Integrated Insulin Pumps, Blood Glucose, Manufacturers, Global Health, IPRO Glucose, MARD, SMBG, Growing Diabetic Population, Type 1&2 Diabetes, Nocturnal Hypoglycemia) - Gluc

  • $ 4 000
  • Industry report
  • January 2015
  • by Occams

Emergence of continuous glucose monitoring systems is a major breakthrough in the glucose monitoring for diabetic patients. Medtronic and Dexcom are the only major players in this industry followed by ...

2015 Deep Research Report on Global Recombinant Human Insulin Industry

2015 Deep Research Report on Global Recombinant Human Insulin Industry

  • $ 2 600
  • Industry report
  • January 2015
  • by QY Research Group

Summary 2015 Deep Research Report on Global Recombinant Human Insulin Industry is a professional and depth research report on Global Recombinant Human Insulin industry. For overview analysis, the report ...

Vildagliptin  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Vildagliptin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

Glimepiride, Pioglitazone  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Glimepiride, Pioglitazone - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

Metformin, Vildagliptin  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Metformin, Vildagliptin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

About 3 000 reports for Insulin

Download Unlimited Documents from Trusted Public Sources

Novo Nordisk Annual Report 2013

  • January 2013
    116 pages
  • Diabete  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.